Triangle Securities Wealth Management Buys 15 Shares of Medtronic PLC (MDT)
Triangle Securities Wealth Management boosted its stake in shares of Medtronic PLC (NYSE:MDT) by 0.3% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,396 shares of the medical technology company’s stock after acquiring an additional 15 shares during the quarter. Triangle Securities Wealth Management’s holdings in Medtronic PLC were worth $390,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors also recently bought and sold shares of MDT. Waldron LP acquired a new stake in Medtronic PLC during the 1st quarter worth approximately $512,000. Acadian Asset Management LLC acquired a new stake in Medtronic PLC during the 1st quarter worth approximately $694,000. Duncker Streett & Co. Inc. lifted its position in Medtronic PLC by 4.7% during the 1st quarter. Duncker Streett & Co. Inc. now owns 16,564 shares of the medical technology company’s stock worth $1,334,000 after acquiring an additional 741 shares during the period. Baystate Wealth Management LLC lifted its position in Medtronic PLC by 40.9% during the 1st quarter. Baystate Wealth Management LLC now owns 1,959 shares of the medical technology company’s stock worth $157,000 after acquiring an additional 569 shares during the period. Finally, Granite Investment Partners LLC lifted its position in Medtronic PLC by 6.1% during the 1st quarter. Granite Investment Partners LLC now owns 134,466 shares of the medical technology company’s stock worth $10,833,000 after acquiring an additional 7,724 shares during the period. 80.75% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: “Triangle Securities Wealth Management Buys 15 Shares of Medtronic PLC (MDT)” was first reported by Daily Political and is the property of of Daily Political. If you are reading this piece on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece can be read at https://www.dailypolitical.com/2017/09/11/triangle-securities-wealth-management-buys-15-shares-of-medtronic-plc-mdt.html.
A number of analysts have weighed in on MDT shares. CIBC reaffirmed a “buy” rating on shares of Medtronic PLC in a research report on Friday, May 26th. Needham & Company LLC reissued a “buy” rating and issued a $95.00 price target (up from $91.00) on shares of Medtronic PLC in a report on Thursday, May 25th. Oppenheimer Holdings, Inc. reissued a “buy” rating and issued a $93.00 price target (up from $87.00) on shares of Medtronic PLC in a report on Thursday, May 25th. UBS AG reissued a “buy” rating and issued a $95.00 price target (up from $94.00) on shares of Medtronic PLC in a report on Tuesday, May 30th. Finally, BidaskClub cut Medtronic PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Two investment analysts have rated the stock with a sell rating, ten have given a hold rating and thirteen have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $88.78.
Medtronic PLC (NYSE MDT) traded down 0.323% during trading on Monday, reaching $81.765. The company’s stock had a trading volume of 2,960,669 shares. Medtronic PLC has a 52 week low of $69.35 and a 52 week high of $89.72. The firm has a 50-day moving average price of $82.58 and a 200-day moving average price of $83.65. The firm has a market capitalization of $111.36 billion, a P/E ratio of 27.521 and a beta of 1.03.
Medtronic PLC (NYSE:MDT) last posted its quarterly earnings results on Tuesday, August 22nd. The medical technology company reported $1.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.08 by $0.04. Medtronic PLC had a net margin of 13.75% and a return on equity of 12.92%. The business had revenue of $7.39 billion for the quarter, compared to the consensus estimate of $7.44 billion. During the same period in the prior year, the business posted $1.03 earnings per share. Medtronic PLC’s revenue for the quarter was up 3.1% compared to the same quarter last year. On average, equities analysts anticipate that Medtronic PLC will post $4.77 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 20th. Stockholders of record on Friday, September 29th will be paid a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.24%. The ex-dividend date is Thursday, September 28th. Medtronic PLC’s dividend payout ratio (DPR) is presently 61.95%.
In related news, EVP Bryan C. Hanson sold 12,000 shares of the company’s stock in a transaction on Monday, July 17th. The shares were sold at an average price of $88.57, for a total value of $1,062,840.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard H. Anderson acquired 5,600 shares of the firm’s stock in a transaction that occurred on Wednesday, June 21st. The stock was acquired at an average price of $88.90 per share, with a total value of $497,840.00. Following the completion of the acquisition, the director now directly owns 71,910 shares of the company’s stock, valued at approximately $6,392,799. The disclosure for this purchase can be found here. Corporate insiders own 0.31% of the company’s stock.
Medtronic PLC Company Profile
Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.
Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.